Promoter entity acquires shares in Bharat Parenterals

1 min read     Updated on 30 Jun 2026, 11:24 AM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Promoter entity Desai Shares and Stock Private Limited acquired 1,356 equity shares in Bharat Parenterals Limited through open market transactions between June 15 and June 25, 2026. The purchase, valued at ₹18.06 lakh, increased the promoter's holding from 39.65% to 39.67%. The disclosure was made under Regulation 29 of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

powered bylight_fuzz_icon
44021884

*this image is generated using AI for illustrative purposes only.

Promoter entity Desai Shares and Stock Private Limited has increased its stake in Bharat Parenterals Limited through an open market acquisition. The entity purchased 1,356 equity shares, raising its total holding to 39.67% of the company's paid-up share capital. The transaction was executed on the BSE and intimated to the company on June 26, 2026.

The acquisition was carried out over a period between June 15, 2026, and June 25, 2026. The total value of the transaction amounted to ₹18.06 lakh. Prior to this purchase, the promoter held 27,32,436 shares, representing a 39.65% stake in the pharmaceutical company.

Details of Acquisition

The disclosure was submitted in accordance with Regulation 29 of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The table below outlines the specifics of the shareholding change:

Particulars Details
Acquirer Desai Shares and Stock Private Limited (Promoter)
Category Promoter
Securities Acquired Equity Shares
Number of Shares 1,356
Transaction Value ₹18,06,434/-
Mode of Acquisition Open Market
Exchange BSE
Date of Allotment June 15, 2026 to June 25, 2026
Pre-acquisition Holding 27,32,436 shares (39.65%)
Post-acquisition Holding 27,33,792 shares (39.67%)

The disclosure was signed by Mr. Bhahim Desai, Director of Desai Shares and Stock Private Limited. Bharat Parenterals Limited's Company Secretary and Compliance Officer, Sharmin Soni, submitted the intimation to the stock exchanges on June 26, 2026.

Historical Stock Returns for Bharat Parenterals

1 Day5 Days1 Month6 Months1 Year5 Years
-1.77%-2.45%+2.40%+12.39%-9.61%+256.32%

Does this incremental increase signal a potential larger acquisition plan by the promoter in the near future?

How might this consolidation of promoter stake influence Bharat Parenterals' strategic decision-making moving forward?

Will this move trigger any reassessment of the stock's valuation by institutional investors?

Desai Shares raises stake to 39.65% in Bharat Parenterals

1 min read     Updated on 16 Jun 2026, 05:10 PM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Desai Shares and Stock Private Limited, a promoter of Bharat Parenterals Limited, acquired 900 equity shares via open market transactions on BSE, increasing its holding to 39.65%. The shares were purchased between June 3 and June 12, 2026, for a total value of ₹12,62,164. The disclosure was submitted under SEBI (Prohibition of Insider Trading) Regulations.

powered bylight_fuzz_icon
43149407

*this image is generated using AI for illustrative purposes only.

Desai Shares and Stock Private Limited, a promoter group entity, has increased its shareholding in Bharat Parenterals Limited to 39.65% following the acquisition of 900 equity shares. The transaction was executed through the open market on BSE Limited between June 3, 2026, and June 12, 2026. The acquirer previously held 39.63% of the company's total voting capital.

The disclosure was filed under Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015. Prior to the acquisition, Desai Shares and Stock Private Limited held 27,31,536 shares carrying voting rights. The recent purchase of 900 shares, valued at ₹12,62,164, has raised its total holding to 27,32,436 shares.

Bharat Parenterals Limited's equity share capital consists of 68,91,963 equity shares of ₹10 each. The acquisition represents a marginal increase in the acquirer's stake relative to the company's total share capital. The filing confirms that the acquirer belongs to the promoter or promoter group of the target company.

The disclosure was signed by Bhahim Desai, Director of Desai Shares and Stock Private Limited. The shares of Bharat Parenterals Limited are listed on BSE Limited with the script code 541096.

Shareholding Details

Description Number of Shares % of Total Share Capital
Holding Before Acquisition
Shares carrying voting rights 27,31,536 39.63%
Acquisition Details
Shares acquired 900 0.013%
Holding After Acquisition
Total shares held 27,32,436 39.65%

Transaction Information

Parameter Details
Mode of Acquisition On Market
Acquisition Period June 3, 2026 to June 12, 2026
Target Company Bharat Parenterals Limited
Stock Exchange BSE Limited

Historical Stock Returns for Bharat Parenterals

1 Day5 Days1 Month6 Months1 Year5 Years
-1.77%-2.45%+2.40%+12.39%-9.61%+256.32%

Does this marginal increase in promoter shareholding signal a potential strategy for further stake consolidation in the near future?

How might this open market acquisition influence investor confidence and the stock's liquidity in the upcoming quarter?

Are there any upcoming corporate actions, such as a buyback or delisting, that could be motivating the promoter group to increase its holding?

More News on Bharat Parenterals

Must Read Next

Earnings

Corporate Actions

Stocks

1 Year Returns:-9.61%